Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CNMD · against 1,372 other Healthcare companies
Ranked #1,093 of 1,373 · scores higher than 20% of peers · safety percentile 20
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 20–29, including CNMD · Click a bar to see the companies
Mainly because of its debt / equity, current ratio and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | CNMD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.80× | 0.24× | 19% | 33% | |
| BetaLower is better · 1,320 reported | 0.94 | 0.53 | 27% | 33% | |
| Current ratioHigher is better · 1,338 reported | 1.48× | 2.62× | 26% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 1,089 | 45.9B USD | 21 | 61 | |
| 1,090 | 37.6B JPY (≈$256M) | 21 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 58 |
| 1,091 | 2.0B USD | 21 | 29 |
| 1,092 | 97.5B USD | 20 | 67 |
| 1,093 | 1.4B USD | 20 | 42 |
| 1,094 | 66.0B BRL (≈$11.9B) | 20 | 55 |
| 1,095 | 1.2B USD | 20 | 75 |
| 1,096 | 24M SEK (≈$2M) | 20 | 14 |
| 1,097 | 168.6B INR (≈$2.0B) | 20 | 63 |